Thorp JA, Hu DH, Albin RM, McNitt J, Meyer BA, Cohen GR, Yeast JD. The effect ofintrapartum epi<strong>du</strong>ral analgesia on nulliparous labor: A randomized, controlled,prospective trial. Am J Obstet Gynecol 1993;169(4):851-8.Thubisi M, Ebrahim A, Moodley J, Shweni PM. Vaginal delivery after previous caesareansection: Is X-ray pelvimetry necessary? Br J Obstet Gynaecol 1993;100(5):421-4.Thurnau GR, Scates DH, Morgan MA. The fetal-pelvic index: A method of identifying fetalpelvicdisproportion in women attempting vaginal birth after previous cesarean delivery.Am J Obstet Gynecol 1991;165(2):353-8.Torloni MR, Betran AP, Souza JP, Widmer M, Allen T, Gulmezoglu M, Merialdi M.Classifications for cesarean section: A systematic review. PLoS One 2011;6(1):e14566.Torres J, Kopplin E, Peña V, Klaus M, Salinas R, Herrera M. Impacto del apoyo emocional<strong>du</strong>rante el parto en la disminución de cesáreas y gratificación del proceso. Rev ChilObstet Ginecol 1999;64(5):405-12.Torvaldsen S, Roberts CL, Bell JC, Raynes-Greenow CH. Discontinuation of epi<strong>du</strong>ral analgesialate in labour for re<strong>du</strong>cing the adverse delivery outcomes associated with epi<strong>du</strong>ralanalgesia. Cochrane Database Syst Rev 2004;(4):CD004457.Troostwijk AL, van Veen JB, Doesburg WH. Pre-in<strong>du</strong>ction intracervical application of a highlyviscous prostaglandin E2 gel in pregnant women with an unripe uterine cervix: A doubleblindplacebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 1992;43(2):105-11.Troyer LR et Parisi VM. Obstetric parameters affecting success in a trial of labor: Designation ofa scoring system. Am J Obstet Gynecol 1992;167(4 Pt 1):1099-104.Tylleskär J, Finnström O, Leijon I, Hedenskog S, Rydén G. Spontaneous labor and electivein<strong>du</strong>ction—A prospective randomized study. I. Effects on mother and fetus. Acta ObstetGynecol Scand 1979;58(6):513-8.UK Amniotomy Group. Comparing routine versus delayed amniotomy in spontaneous first laborat term. A multicenter randomized trial. Online J Curr Clin Trials 1994;3:122.Ulmsten U, Ekman G, Belfrage P, Bygdeman M, Nyberg C. Intracervical versus intravaginalPGE2 for in<strong>du</strong>ction of labor at term in patients with an unfavorable cervix. Arch Gynecol1985;236(4):243-8.Valentine BH. Intravenous oxytocin and oral prostaglandin E2 for ripening of the unfavourablecervix. Br J Obstet Gynaecol 1977;84(11):846-54.Van der Spank JT, Cambier DC, De Paepe HM, Danneels LA, Witvrouw EE, Beerens L. Painrelief in labour by transcutaneous electrical nerve stimulation (TENS). Arch GynecolObstet 2000;264(3):131-6.Van der Walt D et Venter PF. Management of term pregnancy with premature rupture of themembranes and unfavourable cervix. S Afr Med J 1989;75(2):54-6.192
Vintzileos AM, Antsaklis A, Varvarigos I, Papas C, Sofatzis I, Montgomery JT. A randomizedtrial of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation.Obstet Gynecol 1993;81(6):899-907.Vinueza CA, Chauhan SP, Barker L, Hendrix NW, Scardo JA. Predicting the success of a trial oflabor with a simple scoring system. J Reprod Med 2000;45(4):332-6.Visco AG, Viswanathan M, Lohr KN, Wechter ME, Gartlehner G, Wu JM, et al. Cesareandelivery on maternal request: Maternal and neonatal outcomes. Obstet Gynecol2006;108(6):1517-29.Volmanen P, Sarvela J, Akural EI, Raudaskoski T, Korttila K, Alahuhta S. Intravenousremifentanil vs. epi<strong>du</strong>ral levobupivacaine with fentanyl for pain relief in early labour: Arandomised, controlled, double-blinded study. Acta Anaesthesiol Scand 2008;52(2):249-55.Wagner MV, Chin VP, Peters CJ, Drexler B, Newman LA. A comparison of early and delayedin<strong>du</strong>ction of labor with spontaneous rupture of membranes at term. Obstet Gynecol1989;74(1):93-7.Wei S, Wo BL, Xu H, Luo ZC, Roy C, Fraser WD. Early amniotomy and early oxytocin forprevention of, or therapy for, delay in first stage spontaneous labour compared withroutine care. Cochrane Database Syst Rev 2009a;(2):CD006794.Wei SQ, Luo ZC, Xu H, Fraser WD. The effect of early oxytocin augmentation in labor: A metaanalysis.Obstet Gynecol 2009b;114(3):641-9.Wennerholm UB, Hagberg H, Brorsson B, Bergh C. In<strong>du</strong>ction of labor versus expectantmanagement for post-date pregnancy: Is there sufficient evidence for a change in clinicalpractice? Acta Obstet Gynecol Scand 2009;88(1):6-17.Wetrich DW. Effect of amniotomy upon labor. A controlled study. Obstet Gynecol1970;35(5):800-6.Wing DA, Guberman C, Fassett M. A randomized comparison of oral mifepristone to intravenousoxytocin for labor in<strong>du</strong>ction in women with prelabor rupture of membranes beyond 36weeks' gestation. Am J Obstet Gynecol 2005;192(2):445-51.Wing DA, Fassett MJ, Mishell DR. Mifepristone for prein<strong>du</strong>ction cervical ripening beyond 41weeks' gestation: A randomized controlled trial. Obstet Gynecol 2000;96(4):543-8.Wingerup L, Andersson KE, Ulmsten U. Ripening of the uterine cervix and in<strong>du</strong>ction of labour atterm with prostaglandin E2 in viscous gel. Acta Obstet Gynecol Scand 1978;57(5):403-6.Wiqvist I, Norström A, Wiqvist N. In<strong>du</strong>ction of labor by intra-cervical PGE2 in viscous gel.Mechanism of action and clinical treatment routines. Acta Obstet Gynecol Scand1986;65(5):485-92.Wiriyasirivaj B, Vutyavanich T, Ruangsri RA. A randomized controlled trial of membranestripping at term to promote labor. Obstet Gynecol 1996;87(5 Pt 1):767-70.193
- Page 1 and 2:
ANNEXES DU RAPPORTMesures prometteu
- Page 3 and 4:
Tableau B-6 Les études cliniques i
- Page 5 and 6:
PubMedSURVEILLANCE FŒTALE ÉLECTRO
- Page 7 and 8:
PubMedACCÉLÉRATION DU TRAVAILRech
- Page 9 and 10:
De plus, en utilisant les mêmes co
- Page 11:
Tableau B-2b Les essais cliniques r
- Page 14 and 15:
Evron, 2007Shifman, 2007Nafisi, 200
- Page 16 and 17:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 18 and 19:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 20 and 21:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 22 and 23:
Tableau B-7 Les études cliniques i
- Page 24 and 25:
Thurnau, 1991 (P)xPickhardt, 1992 (
- Page 26 and 27:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 28 and 29:
REVUESSYSTÉMATIQUESLiu et Sia, 200
- Page 30 and 31:
Tableau C-4 La description des revu
- Page 32 and 33:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 34 and 35:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 36 and 37:
REVUESSYSTÉMATIQUESWei, 2009aCanad
- Page 38 and 39:
Tableau C-6 La description des revu
- Page 40 and 41:
Tableau C-7 La description des revu
- Page 42 and 43:
REVUESSYSTÉMATIQUESKhunpradit, 201
- Page 44 and 45:
ANNEXE D CARACTÉRISTIQUES DES ÉTU
- Page 46 and 47:
REVUESSYSTÉMATIQUESHowarth et Bota
- Page 48 and 49:
ANNEXE E RECENSEMENT DES ÉLÉMENTS
- Page 50 and 51:
Conditions INTRApartum jamaisinclus
- Page 52 and 53:
ANNEXE F EXERCICES D’INTERPRÉTAT
- Page 54 and 55:
F.1 ANALGÉSIE PÉRIDURALEF.1.1 EXE
- Page 56 and 57:
3. Les implications sur la pratique
- Page 58 and 59:
5. Les enjeux éthiquesPeut-il y av
- Page 60 and 61:
F.1.2 SOMMAIRE DES COMMENTAIRES RE
- Page 62 and 63:
Question 3Les implications sur la p
- Page 64 and 65:
Question 4Facilitateurs pour les al
- Page 66 and 67:
Éléments de mesureConcernant la p
- Page 68 and 69:
F.2 SURVEILLANCE FŒTALE ÉLECTRONI
- Page 70 and 71:
4. Les implications sur la pratique
- Page 72 and 73:
6. Les enjeux éthiquesSi on vous d
- Page 74 and 75:
ENCERCLEZ les conditions antepartum
- Page 76 and 77:
Évaluation de l’exerciceMerci d
- Page 78 and 79:
Question 3Facteurs liés à la non-
- Page 80 and 81:
Question 5Avantages et inconvénien
- Page 82 and 83:
Question 6Arguments de nature éthi
- Page 84 and 85:
Éléments de mesuresConcernant la
- Page 86 and 87:
F.3 DÉCLENCHEMENT ET ACCÉLÉRATIO
- Page 88 and 89:
3. Des mesures pour optimiser le re
- Page 90 and 91:
Évaluation de l’exerciceMerci d
- Page 92 and 93:
Éviter l’analgésie périduralee
- Page 94 and 95:
péridurale.Manque de préparation
- Page 96 and 97:
Considérant que le déclenchement
- Page 98 and 99:
4. Les enjeux éthiquesIniquités d
- Page 100 and 101:
F.4 CÉSARIENNEF.4.1 EXERCICE D’I
- Page 102 and 103:
3. Les implications sur la pratique
- Page 104 and 105:
5. Les enjeux éthiquesIniquités d
- Page 106 and 107:
F.4.2 SOMMAIRE DES COMMENTAIRES RE
- Page 108 and 109:
Question 3Les implications sur la p
- Page 110 and 111:
Question 4Facilitateurs et barrièr
- Page 112 and 113:
Éléments pour mesures (spécifiqu
- Page 114 and 115:
ANNEXE G TRAVAUX AVEC LE COMITÉ DE
- Page 116 and 117:
Programme9 h 30-10 h 00 Accueil et
- Page 118 and 119:
OUTIL DE CONSULTATION1. Cotez de 1
- Page 120 and 121:
accompagnant spécialement formé
- Page 122 and 123:
PertinenceAcceptabilitéFaisabilit
- Page 124 and 125:
PertinenceAcceptabilitéFaisabilit
- Page 126 and 127:
PertinenceAcceptabilitéFaisabilit
- Page 128 and 129:
Bloc 2 : la surveillance fœtale é
- Page 130 and 131:
PertinenceAcceptabilitéFaisabilit
- Page 132 and 133:
PertinenceAcceptabilitéFaisabilit
- Page 134 and 135:
La surveillance fœtale électroniq
- Page 136 and 137:
Dans les grossesses à terme et à
- Page 138 and 139:
PertinenceAcceptabilitéFaisabilit
- Page 140 and 141:
Considérant que l’accélération
- Page 142 and 143:
19691987200120062009Bloc 4 : la cé
- Page 144 and 145:
Contribution au taux général de c
- Page 146 and 147: (2001) et de diffuser périodiqueme
- Page 148 and 149: Mesures pour réduire le recours à
- Page 150 and 151: La césarienne2. Suggestions pour d
- Page 152 and 153: culture de la naissance. C’est au
- Page 154 and 155: contrer la tendance à recourir aux
- Page 156 and 157: FACTEURS ASSOCIÉS : Sensibiliser l
- Page 158 and 159: 154- (ce libellé est) contre-produ
- Page 160 and 161: BLOC 3 - Déclenchement / accélér
- Page 162 and 163: BLOC 4 - CésarienneGÉNÉRAL - MIS
- Page 164 and 165: FACTEURS ASSOCIÉS - GÉNÉRAL : Fa
- Page 166 and 167: Ocytocine pour déclenchement du tr
- Page 168 and 169: Support 1 : 1 (Hodnett, 2011)Nombre
- Page 170 and 171: Anim-Somuah M, Smyth RM, Jones L. E
- Page 172 and 173: Bugg GJ, Siddiqui F, Thornton JG. O
- Page 174 and 175: Cogan R et Spinnato JA. Social supp
- Page 176 and 177: El-Torkey M et Grant JM. Sweeping o
- Page 178 and 179: Gourounti K et Sandall J. Admission
- Page 180 and 181: Hauth JC, Cunningham FG, Whalley PJ
- Page 182 and 183: Huang XH, Xiang XY, Shen RG, Shang
- Page 184 and 185: Larmon JE, Magann EF, Dickerson GA,
- Page 186 and 187: MacKenzie IZ, Bradley S, Embrey MP.
- Page 188 and 189: Morales WJ et Lazar AJ. Expectant m
- Page 190 and 191: Ozden S, Delikara MN, Avci A, Ficic
- Page 192 and 193: Roberts WE, North DH, Speed JE, Mar
- Page 194 and 195: Shifman EM, Butrov AV, Floka SE, Go
- Page 198: Witoonpanich P et Surapong K. Contr